相关实验视频
Updated: Jun 3, 2025

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
383
在与LRRK2相关的帕金森病中α-Synuclein Oligomers的广泛分布
Hiroaki Sekiya1,2,3, Lukas Franke1, Yuki Hashimoto2,3
1Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
bioRxiv : the preprint server for biology
|January 7, 2025
概括
早期帕金森病病理的α-synuclein小分子在LRRK2-PD大脑中普遍存在,即使没有勒维体. 针对这些寡合体可能为LRRK2相关的帕金森病提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 的突变是帕金森病 (PD) 的主要原因.
- LRRK2-PD患者通常缺乏在其他PD形式中见到的典型的Lewy相关病理 (LRP).
- 早期聚合形式的α-synuclein (αSYN) 寡合体与神经毒性有关.
研究的目的:
- 调查LRRK2-PD患者大脑中αSYN寡合体的存在和分布.
- 确定LRRK2-PD中αSYN寡合体和LRP之间的关系.
- 探索LRRK2-PD的潜在治疗点.
主要方法:
- 来自具有致病突变 (p.G2019S,p.I2020T,p.R1441C) 的LRRK2-PD患者的死后脑部部分被分析.
- 使用化αSYN免疫组织化学 (IHC) 和αSYN近距离结合试验 (PLA).
- 对LRP和αSYN寡合物的半定量评估在大脑区域进行.
主要成果:
- 在LRRK2-PD病例中检测到αSYN寡合体,包括那些没有LRP的病例.
- 在LRP严重程度和αSYN寡合物水平之间发现了显著的负相关性 (r=-0.26,P<0.0001).
- 患有p.G2019S和p.I2020T突变的患者在没有LRP的情况下显示出更高的αSYN寡合体,与较短的疾病持续时间相关.
结论:
- αSYN寡合体代表LRRK2-PD中常见的病理特征,可能是LRP形成的前身.
- 这些发现表明,αSYN寡合体可能是LRRK2-PD中神经退行的一个关键驱动因素.
- 向αSYN寡合体可能是LRRK2-PD的有希望的治疗策略,无论LRP是否存在.
相关概念视频
Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Parkinson's Disease: Treatment
215
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
215

